Overview
Byteflies offers certified telemonitoring solutions that transmit vital signs from patients' homes directly to healthcare providers. The company provides remote vital sign measurements and analyses with pay-per-use pricing, handling device logistics and system integration across therapeutic domains including cardiology, neurology, and oncology.
Key people
In the news
- Imagine a 5G-enabled drone arriving at a patient’s side before an ambulance even gets there, carrying an AED that could save their life. That’s what we’ve been exploring through the 5G-CARE project: how real-time medical data and 5G connectivity can enable continuous patient monitoring, speed up diagnosis and support faster emergency response. By combining a wearable 5G hub for continuous monitoring with the deployment of drones, AI and edge computing, we’re taking steps towards a more connected and patient-centered healthcare
- Imagine a 5G-enabled drone arriving at a patient’s side before an ambulance even gets there, carrying an AED that could save their life. ❤️🩹 That’s what we’ve been exploring through the 5G-CARE project: how real-time medical data and 5G connectivity can enable continuous patient monitoring, speed up diagnosis and support faster emergency response. 🚑 By combining a wearable 5G hub for continuous monitoring with the deployment of drones, AI and edge computing, we’re taking steps towards a more connected and patient-centered
- Getting the dose right for children living with Dravet syndrome or Lennox-Gastaut syndrome is never straightforward. These are rare and severe epilepsies, and treatment decisions often rely heavily on caregiver-reported seizure diaries, which may not always capture the full picture. We're excited to be exploring a different approach through the TETRIS study. Using our EpiCare@Home solution, participants undergo 3-7 days of home-based monitoring with reduced-montage EEG, ECG, and movement data collected in their everyday
- Last week marked the kick-off of the HybridLungCare LTX pilot, together with UZ Leuven and KU Leuven. Over the next months, 80 lung transplant patients will log daily at-home measurements of their lung allograft function, vital signs and patient-reported outcomes. For the digital monitoring platform, we partnered with patientMpower. The data flows directly into the care team’s dashboard, enabling real-time remote monitoring and earlier detection of warning signs of post-transplant complications. This pilot is also a step
- Why is telemonitoring still moving so slowly in Belgium? Our CEO, Hans De Clercq, joined Dr. Gianni Faelens on his latest podcast episode to explain how patients with arrhythmias, epilepsy and sleep apnea can be monitored from home and why reimbursement, fragmented health records and complex hospital processes remain major barriers. Thank you, Dr. Gianni Faelens for the thoughtful conversation. 🎧 Listen here: - YouTube: https://lnkd.in/dkYhUeRw - Spotify: https://lnkd.in/d78Vficn
- Why do so many promising health innovations lose momentum after the pilot phase and never reach scale? Join the Biovia panel at HLTH Europe next week, moderated by Kim Luyckx (Biovia), with our CCO Sascha van Belzen joining fellow panelists Ward Servaes (moveUP - digital therapies), Erik Janssen (UCB), and Scott Russell (Innatify). Through real-world use cases, the panel will discuss how value-based healthcare can drive innovation at scale by better aligning hospitals, industry, payers and innovation networks. If you're attending
Alumni 3 went on to found or lead
Bertold Van den BerghSenior Firmware Engineer→Co-founder & Principal Engineer at MAHI
Deepak MuruganEmbedded Software Engineer→Founder & CEO at ClusterVise
Lars VeelaertChief Information Security Officer→CEO & Co-Founder at XFA
Something wrong or missing? Send an update. Fixed within 24 hours.